Heinz-Herbert Fiebig

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Single Molecule

Top Venues

Communications biology

Cancer research communications

4HF Biotec GmbH

This page only lists publications with an associated author ORCID identifier.

Affiliation History

4HF Biotec GmbH Jun 26 2015

Germany

CEO

Publications

Vincent Vuaroqueaux, Alexandra Musch, Anne-Lise Peille, Gerhard Kelter, Loreen Weichert, Thomas Metz, Hans R Hendriks, Heinz-Herbert Fiebig
High in vitro and in vivo activity of BI-847325, a dual MEK/Aurora kinase inhibitor, in human solid and hematologic cancer models. Cancer research communications (2023)
Anne-Lise Peille, Vincent Vuaroqueaux, Swee-Seong Wong, Jason Ting, Kerstin Klingner, Bruno Zeitouni, Manuel Landesfeind, Woo-Ho Kim, Hyuk-Joon Lee, Seong-Ho Kong, Isabella Wulur, Steven Bray, Peter Bronsert, Nina Zanella, Greg Donoho, Han-Kwang Yang, Heinz-Herbert Fiebig, Christoph Reinhard, Amit Aggarwal
Author Correction: Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma. Communications biology 3 (1) (2020)
Anne-Lise Peille, Vincent Vuaroqueaux, Swee-Seong Wong, Jason Ting, Kerstin Klingner, Bruno Zeitouni, Manuel Landesfeind, Woo-Ho Kim, Hyuk-Joon Lee, Seong-Ho Kong, Isabella Wulur, Steven Bray, Peter Bronsert, Nina Zanella, Greg Donoho, Han-Kwang Yang, Heinz-Herbert Fiebig, Christoph Reinhard, Amit Aggarwal
Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma. Communications biology 3 (1) (2020)